Bavarian Nordic partners up with Dynavax on hepatitis B vaccine

The two firms expect to launch the new vaccine in Germany in Q4 2021.
Photo: Bavarian Nordic / PR
Photo: Bavarian Nordic / PR
BY RITZAU FINANS, TRANSLATED BY NIELSINE NIELSEN

Danish pharmaceutical company Bavarian Nordic is entering into a marketing and distribution agreement with Dynavac for the launch of a new hepatitis B vaccine in Germany, according to a press release published on Thursday.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading